Company Nordpharm Srl with Fiscal Code 6077518
recorded a turnover of 2024 of
76.093.415,
with a net profit of
4.210.336
and having an average number of employees of
314.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nordpharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
3.292.649
4.786.444
7.502.018
10.575.704
13.148.083
18.058.087
26.554.685
37.567.018
53.431.023
76.093.415
Total Income - EUR
3.321.886
4.834.841
7.601.690
10.695.679
13.220.892
18.204.936
26.579.908
37.624.416
53.700.973
76.142.793
Total Expenses - EUR
3.176.702
4.468.060
6.930.218
10.175.487
12.574.803
17.499.358
25.384.191
35.128.787
49.834.985
71.324.750
Gross Profit/Loss - EUR
145.185
366.781
671.472
520.192
646.090
705.579
1.195.717
2.495.629
3.865.987
4.818.043
Net Profit/Loss - EUR
115.581
313.712
578.946
441.337
556.553
615.292
1.050.035
2.155.543
3.425.326
4.210.336
Employees
29
43
64
100
113
133
159
188
214
314
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 43.2%, from 53.431.023 euro in the year 2023, to 76.093.415 euro in 2024.
The Net Profit increased by 804.153 euro, from 3.425.326 euro in 2023, to 4.210.336 in the last year.
Check the financial reports for the company - Nordpharm Srl
Financial Rating - NORDPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nordpharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nordpharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nordpharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
37.412.355 euro in 2024 which includes Inventories of
7.996.216 euro, Receivables of
28.746.703 euro and cash availability of
669.437 euro.
The company's Equity was valued at
7.805.214 euro, while total Liabilities amounted to
40.109.320 euro.
Equity increased by 2.245.080 euro, from 5.591.382 euro in 2023, to 7.805.214 in 2024.
The Debt Ratio was 83.7% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nordpharm Srl